May 2013: Cancer Treatment Challenges Symposium


On May 6, 2013, cancer biologists, engineers, and clinicians gathered at the Koch Institute at MIT for an open discussion of the greatest challenges and most promising solutions in cancer care. Speakers included:

Phillip A. Sharp, Institute Professor, Koch Institute at MIT
Sangeeta N. Bhatia, John J. and Dorothy Wilson Professor of Health Sciences and Technology & Electrical Engineering and Computer Science, Koch Institute at MIT
K. Dane Wittrup, Carbon P. Dubbs Professor of Chemical Engineering and Bioengineering, Koch Institute at MIT
Michael B. Yaffe, David H. Koch Professor of Biology and Biological Engineering, Koch Institute at MIT
Catherine J. Wu, Associate Physician, Medical Oncology, Dana-Farber Cancer Institute
Jay S. Loeffler, Chief, Radiation Oncology, Massachusetts General Hospital
Matthew R. Smith, Director, Genitourinary Malignancies Program, Massachusetts General Hospital Cancer Center
Steven P. Balk, Staff Physician, Hematology/Oncology, Beth Israel Deaconess Medical Center

The event also featured presentations by researchers working on existing Bridge Project teams:

Christopher Love, Koch Institute at MIT, Hidde Ploegh, Whitehead Institute and Koch Institute at MIT, and Kai W. Wucherpfennig, Dana-Farber Cancer Institute
Novel Immunotherapies Against Pancreatic Cancer

Elazer Edelman, Institute of Medical Engineering and Sciences at MIT and Koch Institute at MIT and Jeffrey W. Clark, Massachusetts General Hospital
A Pancreatobiliary Chemotherapy Eluting Stent for Pancreatic Ductal Adenocarcinomas

Rakesh K. Jain, Massachusetts General Hospital and Robert Langer, Koch Institute at MIT
Angiotensin Receptor Blockers (ARBs) as a Novel Approach to Improve Drug Delivery in the Treatment of Pancreatic Cancer

Keith L. Ligon, Dana-Farber Cancer Institute and J. Christopher Love, Koch Institute at MIT
Single-Cell Functional, Genomic and Transcriptomic Analysis in Glioblastoma